Heptares partners with AstraZeneca to discover and develop products targeting G-protein coupled receptors (GPCRs) to treat CNS/pain, cardiovascular/metabolic and inflammatory disorders

Heptares Therapeutics Ltd.

U.K. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

AstraZeneca plc

U.K. / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced